After MEM completed its pivotal clinical trial in March 2025, which resulted in the Felix device being declared 'best in class", MEM has been actively seeking commercial partnerships.
MEM is clearly and actively working in this area and the conditions in USA seem ripe for a deal to occur.
So, soon means that the potential clearly and notably exists, but a defined time frame is impossible to predict.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.917M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 12820865 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5420722 | 10 |
View Market Depth
| Last trade - 16.21pm 25/07/2025 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable